The result that starts the shift

A coagulation result lands in the queue with an isolated prolonged activated partial thromboplastin time (aPTT). The prothrombin time (PT) is normal. There is no prior coagulation history on file, no documented bleeding, and no note about how the specimen was drawn. Nothing tells you yet whether this is a real hemostatic problem, a specimen issue, or a medication effect.

The same reasoning applies across every case: a screening result surfaces, and the immediate question is not what disease it names but what the next defensible laboratory action is.

An isolated prolonged aPTT with an unknown history could reflect an unfractionated heparin line contamination, a factor VIII, IX, or XI deficiency, a lupus anticoagulant, or a specific factor inhibitor. Naming any one of these before checking the specimen and the collection history is premature. A prolonged screening clotting time is an observation that requires confirmation and context, not a diagnosis.

Before any interpretation begins, ask how the specimen was drawn, what medications the patient is on, and what the reference interval and method actually cover, because the answer changes which explanation is even in play.